Medical Developments Overview

  • Founded
  • 1971
Founded
  • Status
  • Public
  • Employees
  • 68
Employees
  • Stock Symbol
  • MVP
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $2.11
  • (As of Friday Closing)

Medical Developments General Information

Description

Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors (Healthcare)
Other Industries
Therapeutic Devices
Medical Supplies
Stock Exchange
ASX
Primary Office
  • 4 Caribbean Drive
  • Scoresby, Victoria 3179
  • Australia
+61 (03) 0000 0000

Medical Developments Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medical Developments Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.11 $1.98 $1.97 - $4.03 $151M 71.3M 80.4K -$0.20

Medical Developments Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 239,988 215,982 306,362 220,217
Revenue 16,724 18,841 15,094 14,927
EBITDA (14,585) (8,334) 1,806 2,460
Net Income (14,107) (9,368) 254 742
Total Assets 69,609 75,265 58,240 59,389
Total Debt 2,126 2,291 2,306 127
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medical Developments Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medical Developments‘s full profile, request access.

Request a free trial

Medical Developments Executive Team (2)

Name Title Board Seat Contact Info
Mark Edwards Chief Financial Officer & Secretary
You’re viewing 1 of 2 executive team members. Get the full list »

Medical Developments Board Members (3)

Name Representing Role Since
00000 00000000 00.0 Self Board Member 000 0000
0000 00000 Self Board Member 000 0000
0000 0000000 Medical Developments Board Member 000 0000
To view Medical Developments’s complete board members history, request access »

Medical Developments Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medical Developments Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 05-Feb-2016 0000000000 00.000 Therapeutic Devices
To view Medical Developments’s complete acquisitions history, request access »